Beta-lactamase inhibitors and methods of use thereof

Details for Australian Patent Application No. 2004256841 (hide)

Owner Fulcrum Pharmaceuticals, Inc. The Johns Hopkins University

Inventors Ottenbrite, Raphael; Luque, Irene; Freire, Ernesto; Xiao, Yingxin; Ross, Patrick

Agent Davies Collison Cave

Pub. Number AU-A-2004256841

PCT Pub. Number WO2005/004799

Priority 60/477,636 10.06.03 US

Filing date 10 June 2004

Wipo publication date 20 January 2005

International Classifications

A61K 31/381 (2006.01) - having five-membered rings

C07D 327/04 (2006.01) Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms

Event Publications

5 January 2006 PCT application entered the National Phase

  PCT publication WO2005/004799 Priority application(s): WO2005/004799

3 April 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004256852-Method for robust scale-space analysis of 3D local structures in medical images

2004256839-Multi-layered photobioreactor and method of culturing photosynthetic microorganisms using the same